Business Context and Reporting Period
This Form 6-K filing by Ping An Biomedical Co., Ltd. (also referred to as Linkers Industries Limited in the text) covers the month of November 2025, with the report dated November 28, 2025. The filing addresses a regulatory compliance issue regarding the company's listing status on The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a listing deficiency notice rather than financial performance data.
Material Changes and Events
- Nasdaq Non-Compliance: On November 24, 2025, the Company received a deficiency letter from Nasdaq stating it failed to meet the minimum bid price requirement of $1.00 per share under Rule 5550(a)(2).
- Deficiency Period: The non-compliance was based on the closing bid price from October 10, 2025, to November 20, 2025.
- Compliance Timeline: Nasdaq has granted an initial 180-day compliance period, extending until May 25, 2026, to regain compliance.
Outlook, Risks, and Management Commentary
Management is currently evaluating options to regain compliance, including the potential implementation of a reverse stock split. The Company intends to use all reasonable efforts to meet the requirement but explicitly states there can be no assurance of success. If the Company fails to regain compliance by the deadline, it may be eligible for an additional 180-day period if it meets other listing standards (such as market value of publicly held shares) and provides written notice of its intent to cure. Failure to cure the deficiency ultimately subjects the Company's securities to delisting.
Investor Verification Checklist
- Verify the current stock bid price to assess the severity of the deficiency.
- Monitor for announcements regarding a reverse stock split or other capital structure changes.
- Review the press release filed as Exhibit 99.1 for additional details on management's specific remediation plan.
- Track the company's progress toward the May 25, 2026, compliance deadline to gauge delisting risk.